Margarit Carlos, Escartín Alfredo, Castells Lluis, Vargas Víctor, Allende Elena, Bilbao Itxarone
Liver Transplantation Unit, Department of Surgery, Hospital Vall Hebrón, Universidad Autónoma, Barcelona, Spain.
Liver Transpl. 2005 Oct;11(10):1242-51. doi: 10.1002/lt.20398.
The best treatment option for patients with single, early hepatocellular carcinoma (HCC) and cirrhosis, good liver function, and absence of portal hypertension remains to be established. The aim of this work was to compare the outcome of liver resection (LR) with that of liver transplantation (LT) for single, early HCC in Child-Turcotte-Pugh class A patients with cirrhosis younger than 70 years of age. Thirty-seven of 134 patients who underwent LR and 36 of 125 who underwent LT for HCC in our unit fulfilled the inclusion criteria. No differences were observed in mean tumor size (3 cm); HCV cirrhosis predominated in the LT group and older age in the LR group. Postoperative mortality was higher and hospital stay longer in the LT group. Patient survival was similar in both groups. Tumor recurrence was higher in the LR group (59% vs. 11%), extrahepatic recurrences predominated after LT and hepatic recurrences after LR. Disease-free survival was significantly better after LT. Eighteen patients presented hepatic recurrence after LR: 5 advanced and 13 early. Seventeen patients--13 with early HCC recurrence and 4 with liver failure--were potential candidates for salvage LT. However, 10 of 17 patients were older than 70 years at this time. Salvage LT could only be performed in 6 patients: 5 for HCC recurrence and 1 for liver failure. Results of salvage LT were similar to those of primary LT. In conclusion, only 27.6% of resected patients were eligible for LT. LR is a good option since it offers similar survival to LT. Salvage liver transplantation was performed in 16.2% of resected patients, with older age being the main contraindication. Outcome of salvage LT was similar to that of primary LT.
对于单发早期肝细胞癌(HCC)合并肝硬化、肝功能良好且无门静脉高压的患者,最佳治疗方案仍有待确定。本研究的目的是比较肝切除术(LR)与肝移植术(LT)治疗70岁以下Child-Turcotte-Pugh A级肝硬化单发早期HCC患者的疗效。在我们单位,134例行LR治疗的患者中有37例、125例行LT治疗的患者中有36例符合纳入标准。两组患者的平均肿瘤大小(3 cm)无差异;LT组以丙型肝炎病毒(HCV)肝硬化为主,LR组患者年龄较大。LT组术后死亡率较高,住院时间较长。两组患者的总生存率相似。LR组的肿瘤复发率较高(59%对11%),LT术后肝外复发为主,LR术后肝内复发为主。LT术后无病生存率明显更好。18例患者LR术后出现肝内复发:5例为进展期,13例为早期。17例患者——13例早期HCC复发患者和4例肝功能衰竭患者——是挽救性LT的潜在候选者。然而,17例患者中有10例此时年龄超过70岁。仅6例患者可行挽救性LT:5例因HCC复发,1例因肝功能衰竭。挽救性LT的结果与初次LT相似。总之,仅27.6%的肝切除患者符合LT标准。LR是一个不错的选择,因为它与LT的生存率相似。16.2% 的肝切除患者接受了挽救性肝移植,年龄较大是主要的禁忌证。挽救性LT的结果与初次LT相似。